Research records indexed for Thymosin alpha 1
This page carries 12 of the 746 records that the literature query returned for Thymosin alpha 1, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 734 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Thymosin alpha 1.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells pmid:32442287 | 2020 | Research Support, Non-U.S. Gov't, research-article | other | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Thymus Gland; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Lymphopenia; Retrospective Studies. |
| Thymosin alpha 1 treatment for patients with sepsis pmid:30063866 | 2018 | Research Support, Non-U.S. Gov't, Review | other | Not stated | Indexed as research support, non-u.s. gov't, review. study model from MeSH "Humans" with no interventional publication type. subject headings: Sepsis; Adjuvants, Immunologic; Thymalfasin. |
| Thymosin alpha 1 and HIV-1: recent advances and future perspectives pmid:28106477 | 2017 | Review | other | Not stated | Indexed as review. study model from MeSH "Humans" with no interventional publication type. subject headings: Lymphocytes; HIV-1; HIV Infections; Thymosin; Anti-HIV Agents. |
| Immune Modulation with Thymosin Alpha 1 Treatment pmid:27450734 | 2016 | Review | rodent | Not stated | Indexed as review. study model from MeSH "Mice". subject headings: Neoplasms; Immunologic Deficiency Syndromes; Disease Models, Animal; Thymosin; Antineoplastic Agents. |
| Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway pmid:26002438 | 2015 | Research Support, Non-U.S. Gov't | other | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Cell Line, Tumor; Mitochondria; Breast Neoplasms; Thymosin; Signal Transduction. |
| The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial pmid:23327199 | 2013 | Research Support, Non-U.S. Gov't, research-article | human trial | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Sepsis; Thymosin; Adjuvants, Immunologic; Injections, Subcutaneous; Survival Rate. |
| Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma pmid:20194853 | 2010 | Multicenter Study, Randomized Controlled Trial | human trial | Not stated | Indexed as multicenter study, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Melanoma; Dacarbazine; Thymosin; Interferon-Alpha; Antineoplastic Combined Chemotherapy Protocols. |
| In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants pmid:20650309 | 2010 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Mice, Inbred Balb C". subject headings: Mice, Inbred BALB C; Cattle; Rats, Sprague-Dawley; Polyglactin 910; Thymosin. |
| Thymosin alpha 1: biological activities, applications and genetic engineering production pmid:20699109 | 2010 | review-article | other | Not stated | Indexed as review-article. study model from MeSH "Animals" with no rodent species heading. subject headings: Cattle; Thymosin; Recombinant Proteins; Recombinant Fusion Proteins; Antineoplastic Agents. |
| From lab to bedside: emerging clinical applications of thymosin alpha 1 pmid:19392576 | 2009 | Research Support, Non-U.S. Gov't, Review | other | Not stated | Indexed as research support, non-u.s. gov't, review. study model from MeSH "Animals" with no rodent species heading. subject headings: Hepatitis B; Hepatitis C, Chronic; Immune System Diseases; Thymosin; Technology, Pharmaceutical. |
| A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1 pmid:19033321 | 2009 | Randomized Controlled Trial | human trial | Not stated | Indexed as randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Sepsis; Thymosin; Glycoproteins; Adjuvants, Immunologic; Trypsin Inhibitors. |
| Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria pmid:18613793 | 2008 | Randomized Controlled Trial | human trial | Not stated | Indexed as randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Bacteria; Sepsis; Liver Abscess; Cholangitis; Intestinal Obstruction. |
Where this page sits
Compound page: Thymosin alpha 1. Class: Endocrine and immune signalling peptides.
Retrieved 2026-10-10.
Sources
- PubChem Compound Summary for CID 16130571, Thymalfasin. PubChem, National Library of Medicine (2026). pubchem:16130571
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:thymosin-alpha-1
- Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood (2004). pmid:14982877
- Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus. Proceedings of the National Academy of Sciences of the United States of America (1984). pmid:6583693
- The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Critical care (London, England) (2013). pmid:23327199
- Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2020). pmid:32442287
- Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1. Science (New York, N.Y.) (1986). pmid:3010464
- Influences of aging and dietary restriction on serum thymosin alpha 1 levels in mice. Journal of gerontology (1988). pmid:3346517
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.